Invention Grant
- Patent Title: RNAi targeting CNTD2
-
Application No.: US15255829Application Date: 2016-09-02
-
Publication No.: US09719092B2Publication Date: 2017-08-01
- Inventor: Anastasia Khvorova , Angela Reynolds , Devin Leake , William Marshall , Steven Read , Stephen Scaringe
- Applicant: Thermo Fisher Scientific Inc.
- Applicant Address: US MA Waltham
- Assignee: Thermo Fisher Scientific Inc.
- Current Assignee: Thermo Fisher Scientific Inc.
- Current Assignee Address: US MA Waltham
- Agency: Dorf & Nelson LLP
- Agent Scott D. Locke, Esq.
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113 ; A61K31/713

Abstract:
Efficient sequence specific gene silencing is possible through the use of RNAi technology. By selecting particular RNAi molecules by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of RNAi molecules are disclosed including those directed to nucleotide sequences for CNTD2.
Public/Granted literature
- US20160369278A1 RNAi Targeting CNTD2 Public/Granted day:2016-12-22
Information query
IPC分类: